- Report
- October 2025
- 160 Pages
Global
From €2810EUR$3,160USD£2,413GBP
€3513EUR$3,950USD£3,016GBP
- Report
- January 2026
- 160 Pages
Global
From €2810EUR$3,160USD£2,413GBP
€3513EUR$3,950USD£3,016GBP
- Report
- December 2025
- 135 Pages
Global
From €4313EUR$4,850USD£3,703GBP
- Report
- September 2025
- 150 Pages
Global
From €4313EUR$4,850USD£3,703GBP
- Report
- May 2026
- 102 Pages
Middle East
From €3513EUR$3,950USD£3,016GBP
- Report
- May 2026
- 85 Pages
Africa
From €2535EUR$2,850USD£2,176GBP
- Report
- January 2025
- 456 Pages
Global
From €4402EUR$4,950USD£3,779GBP
- Report
- April 2018
- 97 Pages
Global
From €14230EUR$16,000USD£12,216GBP
- Report
- June 2023
- 186 Pages
Global
From €4136EUR$4,650USD£3,550GBP
- Report
- September 2023
- 190 Pages
Global
From €2215EUR$2,490USD£1,901GBP
- Report
- April 2025
- 125 Pages
United States
From €2890EUR$3,250USD£2,481GBP
- Report
- November 2022
- 286 Pages
Global
From €2335EUR$2,625USD£2,004GBP
€4669EUR$5,250USD£4,009GBP
- Report
- May 2025
- 226 Pages
Global
From €2223EUR$2,500USD£1,909GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3113EUR$3,500USD£2,672GBP
- Report
- January 2025
- 180 Pages
Global
From €4002EUR$4,500USD£3,436GBP
- Report
- March 2024
- 200 Pages
Global
From €3691EUR$4,150USD£3,169GBP
- Report
- January 2024
- 200 Pages
Global
From €3691EUR$4,150USD£3,169GBP
- Report
- January 2024
- 257 Pages
Global
From €4447EUR$5,000USD£3,818GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4402EUR$4,950USD£3,779GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4402EUR$4,950USD£3,779GBP

Liver cancer is a type of cancer that originates in the liver, an organ located in the upper right side of the abdomen. It is the fifth most common cancer worldwide and the third leading cause of cancer-related death. Symptoms of liver cancer can include abdominal pain, jaundice, and weight loss. Treatment options for liver cancer include surgery, chemotherapy, radiation therapy, and targeted therapy.
The oncology market for liver cancer is highly competitive, with a range of treatments available. Pharmaceutical companies are investing in research and development to develop new treatments and improve existing ones. Additionally, the market is seeing an increase in the number of clinical trials for new treatments.
Companies in the liver cancer market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more